Bristol Myers Squibb Co. (BMY)
63.38
-0.37
(-0.58%)
USD |
NYSE |
Sep 11, 14:42
Bristol Myers Squibb Gross Profit (TTM) : 32.78B for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 32.78B |
| March 31, 2026 | 32.03B |
| December 31, 2025 | 31.76B |
| September 30, 2025 | 30.90B |
| June 30, 2025 | 29.45B |
| March 31, 2025 | 28.18B |
| December 31, 2024 | 27.43B |
| September 30, 2024 | 26.50B |
| June 30, 2024 | 26.10B |
| March 31, 2024 | 25.43B |
| December 31, 2023 | 25.36B |
| September 30, 2023 | 26.17B |
| June 30, 2023 | 26.01B |
| March 31, 2023 | 26.67B |
| December 31, 2022 | 26.92B |
| September 30, 2022 | 26.80B |
| June 30, 2022 | 27.52B |
| March 31, 2022 | 27.43B |
| December 31, 2021 | 26.76B |
| September 30, 2021 | 25.81B |
| June 30, 2021 | 24.60B |
| March 31, 2021 | 22.94B |
| December 31, 2020 | 21.70B |
| September 30, 2020 | 19.88B |
| June 30, 2020 | 18.53B |
| Date | Value |
|---|---|
| March 31, 2020 | 17.89B |
| December 31, 2019 | 17.12B |
| September 30, 2019 | 17.00B |
| June 30, 2019 | 16.82B |
| March 31, 2019 | 16.52B |
| December 31, 2018 | 16.04B |
| September 30, 2018 | 15.51B |
| June 30, 2018 | 15.15B |
| March 31, 2018 | 14.80B |
| December 31, 2017 | 14.89B |
| September 30, 2017 | 14.80B |
| June 30, 2017 | 14.73B |
| March 31, 2017 | 14.71B |
| December 31, 2016 | 14.50B |
| September 30, 2016 | 13.91B |
| June 30, 2016 | 13.34B |
| March 31, 2016 | 12.79B |
| December 31, 2015 | 12.50B |
| September 30, 2015 | 12.70B |
| June 30, 2015 | 12.49B |
| March 31, 2015 | 12.22B |
| December 31, 2014 | 11.88B |
| September 30, 2014 | 11.90B |
| June 30, 2014 | 12.00B |
| March 31, 2014 | 12.04B |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Johnson & Johnson | 66.63B |
| Eli Lilly & Co. | 66.44B |
| Merck & Co., Inc. | 48.01B |
| Pfizer Inc. | 41.30B |
| AstraZeneca PLC | 44.95B |